The pathway analysis showed that this subset of γδ T cells - Tgd_c21 had decreased activity of the anti-tumor IFN-γ pathway in the non-responders than the responders subjected to the immunotherapy (Fig. 3c). The gene discussed is IFNG; the disease is neoplasm.